Mirna Therapeutics Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
16
- Latest Deal Type
-
M&A
Mirna Therapeutics General Information
Description
Developer of micro ribonucleic acid (miRNA) based oncology therapeutics. The company's miRNA drug kills cancer cells by regaining control over multiple oncogenic pathways.
Contact Information
Website
www.mirnarx.comCorporate Office
- PO Box 163387
- Austin, TX 78716
- United States
Corporate Office
- PO Box 163387
- Austin, TX 78716
- United States
Mirna Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 28-Aug-2017 | Completed | Generating Revenue | |||
| 10. IPO | 30-Sep-2015 | Completed | Clinical Trials - Phase 1 | |||
| 9. Later Stage VC (Series D) | 30-Mar-2015 | Completed | Clinical Trials - Phase 1 | |||
| 8. Grant | 22-May-2014 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC (Series C) | 24-Oct-2012 | Completed | Pre-Clinical Trials | |||
| 6. Early Stage VC (Series B1) | Completed | Product Development | ||||
| 5. Early Stage VC (Series B) | 23-Aug-2011 | Completed | Product Development | |||
| 4. Grant | 01-Jan-2010 | Completed | Product Development | |||
| 3. Grant | 01-Jan-2009 | $5M | $8M | Completed | Product Development | |
| 2. Early Stage VC (Series A) | 01-Jan-2009 | $5M | $8M | Completed | Product Development |
Mirna Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | 540,341 | $0.001000 | $2.78 | $2.11 | 0x | $2.78 | 0.31% | |
| Series A | 3,192,083 | $0.001000 | $2 | $1.33 | 0x | $2 | 1.82% |
Mirna Therapeutics Comparisons
Industry
Financing
Details
Mirna Therapeutics Competitors (79)
One of Mirna Therapeutics’s 79 competitors is Vera Therapeutics, a Formerly VC-backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vera Therapeutics | Formerly VC-backed | Brisbane, CA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Corvus Pharmaceuticals | Formerly VC-backed | South San Francisco, CA | ||||
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Corbus Pharmaceuticals Holdings | Formerly VC-backed | Norwood, MA |
Mirna Therapeutics Patents
Mirna Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140378528-A1 | Biomarkers of mir-34 activity | Inactive | 24-Jun-2013 |
Mirna Therapeutics Signals
Mirna Therapeutics Former Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Asuragen | Corporation | Minority | ||
| Baxalta | Corporation | Minority | ||
| Baxter Ventures | Corporate Venture Capital | Minority | ||
| Cancer Prevention and Research Institute of Texas | Government | Minority | ||
| Celgene | Corporation | Minority |
Mirna Therapeutics Acquisitions (1)
Mirna Therapeutics’s most recent deal was a Reverse Merger with Synlogic. The deal was made on 28-Aug-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Synlogic | 28-Aug-2017 | Reverse Merger | Drug Discovery |
Mirna Therapeutics FAQs
-
When was Mirna Therapeutics founded?
Mirna Therapeutics was founded in 2007.
-
Where is Mirna Therapeutics headquartered?
Mirna Therapeutics is headquartered in Austin, TX.
-
What is the size of Mirna Therapeutics?
Mirna Therapeutics has 16 total employees.
-
What industry is Mirna Therapeutics in?
Mirna Therapeutics’s primary industry is Biotechnology.
-
Is Mirna Therapeutics a private or public company?
Mirna Therapeutics is a Private company.
-
What is Mirna Therapeutics’s current revenue?
The current revenue for Mirna Therapeutics is .
-
How much funding has Mirna Therapeutics raised over time?
Mirna Therapeutics has raised $141M.
-
Who are Mirna Therapeutics’s investors?
Asuragen, Baxalta, Baxter Ventures, Cancer Prevention and Research Institute of Texas, and Celgene are 5 of 18 investors who have invested in Mirna Therapeutics.
-
Who are Mirna Therapeutics’s competitors?
Vera Therapeutics, Kite Pharma, Corvus Pharmaceuticals, Intellia Therapeutics, and Corbus Pharmaceuticals Holdings are some of the 79 competitors of Mirna Therapeutics.
-
When was Mirna Therapeutics acquired?
Mirna Therapeutics was acquired on 28-Aug-2017.
-
Who acquired Mirna Therapeutics?
Mirna Therapeutics was acquired by Synlogic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process